Concord Medical Services Stock Profit Margin
| CCM Stock | USD 0.57 0.01 1.71% |
Concord Medical Services fundamentals help investors to digest information that contributes to Concord Medical's financial success or failures. It also enables traders to predict the movement of Concord Stock. The fundamental analysis module provides a way to measure Concord Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Concord Medical stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | (0.55) | (0.58) |
Concord | Profit Margin |
Concord Medical Services Company Profit Margin Analysis
Concord Medical's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Concord Medical Profit Margin | (0.55) % |
Most of Concord Medical's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Concord Medical Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Concord Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Concord Medical is extremely important. It helps to project a fair market value of Concord Stock properly, considering its historical fundamentals such as Profit Margin. Since Concord Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Concord Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Concord Medical's interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Concord Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Concord Medical Services has a Profit Margin of -0.5539%. This is 95.06% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The profit margin for all United States stocks is 56.39% lower than that of the firm.
Concord Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Concord Medical's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Concord Medical could also be used in its relative valuation, which is a method of valuing Concord Medical by comparing valuation metrics of similar companies.Concord Medical is currently under evaluation in profit margin category among related companies.
Concord Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Concord Medical from analyzing Concord Medical's financial statements. These drivers represent accounts that assess Concord Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Concord Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 806.0M | 781.1M | 556.7M | 494.1M | 341.0M | 324.0M | |
| Enterprise Value | 2.6B | 2.8B | 3.1B | 3.6B | 3.5B | 3.7B |
Concord Fundamentals
| Return On Equity | -0.28 | ||||
| Return On Asset | -0.048 | ||||
| Profit Margin | (0.55) % | ||||
| Operating Margin | (0.98) % | ||||
| Current Valuation | 7.18 B | ||||
| Shares Outstanding | 43.42 M | ||||
| Shares Owned By Insiders | 17.99 % | ||||
| Shares Owned By Institutions | 0.10 % | ||||
| Number Of Shares Shorted | 14.54 K | ||||
| Price To Earning | (3.90) X | ||||
| Price To Book | 3.00 X | ||||
| Price To Sales | 0.04 X | ||||
| Revenue | 537.4 M | ||||
| Gross Profit | (152.41 M) | ||||
| EBITDA | (344.16 M) | ||||
| Net Income | (297.66 M) | ||||
| Cash And Equivalents | 157.39 M | ||||
| Cash Per Share | 1.72 X | ||||
| Total Debt | 3.25 B | ||||
| Debt To Equity | 1.25 % | ||||
| Current Ratio | 0.71 X | ||||
| Book Value Per Share | (48.87) X | ||||
| Cash Flow From Operations | (276.47 M) | ||||
| Short Ratio | 0.64 X | ||||
| Earnings Per Share | (0.94) X | ||||
| Target Price | 1.2 | ||||
| Number Of Employees | 727 | ||||
| Beta | -0.17 | ||||
| Market Capitalization | 25.18 M | ||||
| Total Asset | 6.05 B | ||||
| Retained Earnings | (4.06 B) | ||||
| Working Capital | (1.33 B) | ||||
| Current Asset | 1.51 B | ||||
| Current Liabilities | 1.51 B | ||||
| Net Asset | 6.05 B |
About Concord Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports: Check out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Concord Stock analysis
When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 12.302 | Quarterly Revenue Growth (0.23) | Return On Assets (0.05) | Return On Equity (0.28) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.